Switched from RECO to BYSI (Nasdaq) and it is SOARING.....I switched all of my RECO position into BeyondSpring stock (BYSI) on Nasdaq and, stock has been SOARING.
Stock is now $ 26.87 and, analyst has a $ 100 per share stock price on it.
They did a phase III trial in the USA and China which showed their Plinabulin drug outperforms present day chemo therapy for cancer patients, it extends lifespan by double the amount of chemo and, there is no chemo induced side effects (no vomiting).
They are now seeking FD and China approval for lung cancer in which test was done and, will also be seeking that this drug be applied a whole platform of cancer patients.
Stock carries a market cap of $ 1 billion, has only 39 million shares in circulation of which most are held by insiders and institutions. They are going to target the only real competitior in this field that does revenue of $ 4 billion per year in a market worth $ 9 billion per year. Their drug is better than the competitors.
The competitors drug is owned by Amgen and, it is a real possibility that Amgen will engage in buyout discussions with BeyondSpring as their product will eat into their profits.
A buyout price of $ 3 billion to $ 4 billion means a price $ 100 to $ 150 per share.
Even without the buyout, these companies trade at 5x sales, so if sales are gonna be $ 4 billion per year, it means market cap should be $ 20 billion versus $ 1 billion today or, a 20x jump.
We are now in the SAFE period to invest as phase III results are in and have met all the endpoints. The next catalyst is FDA approval. So between now and FDA approval, this BYSI will soar up many times, much lime Gamestop did.
Thought I would share.
Here is an article with Seeking Alpha which explains the company is simple terms.
https://seekingalpha.com/article/4369313-beyondsprings-plinabulin-offers-multiple-roadmaps-via-multiple-geographies-to-becoming
I made about 1200% and I am aiming at another 1000% on BYSI. You are still early to get in on the rally. Do not miss out.
mpo